We are live on ! Find out more
REPL icon

Replimune Group

101 hedge funds and large institutions have $1.05B invested in Replimune Group in 2021 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 38 increasing their positions, 35 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

933% more call options, than puts

Call options by funds: $31K | Put options by funds: $3K

9% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 35

0.77% more ownership

Funds ownership: 74.81%75.58% (+0.77%)

8% less funds holding

Funds holding: 110101 (-9)

22% less capital invested

Capital invested by funds: $1.34B → $1.05B (-$291M)

64% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 14

67% less funds holding in top 10

Funds holding in top 10: 31 (-2)

Holders
101
Holders Change
-9
Holders Change %
-8.18%
% of All Funds
1.76%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
5
Increased
38
Reduced
35
Closed
14
Calls
$31K
Puts
$3K
Net Calls
+$28K
Net Calls Change
+$493K

REPL Hedge Fund Activity: Q3 2021 in Review

101 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Replimune Group (REPL) for Q3 2021, worth a combined $1.05B — down 22% from $1.34B a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of REPL and 5 opened new positions — a net loss of 9 holders — while 35 trimmed existing stakes and 38 added.

The largest buyer was T. Rowe Price Associates, adding an estimated $21M. The largest seller was Corriente Advisors, exiting entirely with an estimated $17.3M sold.

  • 101 institutional investors held Replimune Group (REPL) as of Q3 2021, down from 110 in Q2 2021.
  • Funds reported $1.05B of Replimune Group stock for Q3 2021, down 22% quarter-over-quarter.
  • 5 funds opened new Replimune Group positions in Q3 2021 and 14 closed out, a net change of -9 holders.
  • The largest Replimune Group buyer in Q3 2021 was T. Rowe Price Associates, an estimated $21M added.
  • The largest Replimune Group seller in Q3 2021 was Corriente Advisors, an estimated $17.3M sold.

Based on aggregated 13F filings for Q3 2021.